GW501516, Cardarine Powders

Basic Information about Cardarine Endurobol GW-501516

GW501516 (also known as GW-501,516, GW1516, GSK-516 and Endurobol, is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.

RETATED PRODUCTS:

Ostarine  MK2866           CAS  841205-47-8

Cardarine  GW501516    CAS  317318-70-0

Nutrobal   MK-677         CAS  159752-10-0

Ligandrol  LGD-4033 CAS  1165910-22-4

Andarine  S4 CAS  401900-40-1

Stenabolic  SR9009 CAS  1379686-30-2

YK-11 CAS  431579-34-9

Testolone  RAD140       CAS  1182367-47-0